BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1939 related articles for article (PubMed ID: 21798893)

  • 1. The mutational landscape of head and neck squamous cell carcinoma.
    Stransky N; Egloff AM; Tward AD; Kostic AD; Cibulskis K; Sivachenko A; Kryukov GV; Lawrence MS; Sougnez C; McKenna A; Shefler E; Ramos AH; Stojanov P; Carter SL; Voet D; Cortés ML; Auclair D; Berger MF; Saksena G; Guiducci C; Onofrio RC; Parkin M; Romkes M; Weissfeld JL; Seethala RR; Wang L; Rangel-Escareño C; Fernandez-Lopez JC; Hidalgo-Miranda A; Melendez-Zajgla J; Winckler W; Ardlie K; Gabriel SB; Meyerson M; Lander ES; Getz G; Golub TR; Garraway LA; Grandis JR
    Science; 2011 Aug; 333(6046):1157-60. PubMed ID: 21798893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1.
    Agrawal N; Frederick MJ; Pickering CR; Bettegowda C; Chang K; Li RJ; Fakhry C; Xie TX; Zhang J; Wang J; Zhang N; El-Naggar AK; Jasser SA; Weinstein JN; Treviño L; Drummond JA; Muzny DM; Wu Y; Wood LD; Hruban RH; Westra WH; Koch WM; Califano JA; Gibbs RA; Sidransky D; Vogelstein B; Velculescu VE; Papadopoulos N; Wheeler DA; Kinzler KW; Myers JN
    Science; 2011 Aug; 333(6046):1154-7. PubMed ID: 21798897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer. Another NOTCH for cancer.
    Brakenhoff RH
    Science; 2011 Aug; 333(6046):1102-3. PubMed ID: 21868662
    [No Abstract]   [Full Text] [Related]  

  • 4. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
    Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR;
    Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma.
    Lim SM; Cho SH; Hwang IG; Choi JW; Chang H; Ahn MJ; Park KU; Kim JW; Ko YH; Ahn HK; Cho BC; Nam BH; Chun SH; Hong JH; Kwon JH; Choi JG; Kang EJ; Yun T; Lee KW; Kim JH; Kim JS; Lee HW; Kim MK; Jung D; Kim JE; Keam B; Yun HJ; Kim S; Kim HR
    Cancer Res Treat; 2019 Jan; 51(1):300-312. PubMed ID: 29747488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleaved NOTCH1 Expression Pattern in Head and Neck Squamous Cell Carcinoma Is Associated with NOTCH1 Mutation, HPV Status, and High-Risk Features.
    Rettig EM; Chung CH; Bishop JA; Howard JD; Sharma R; Li RJ; Douville C; Karchin R; Izumchenko E; Sidransky D; Koch W; Califano J; Agrawal N; Fakhry C
    Cancer Prev Res (Phila); 2015 Apr; 8(4):287-95. PubMed ID: 25633867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
    Seiwert TY; Zuo Z; Keck MK; Khattri A; Pedamallu CS; Stricker T; Brown C; Pugh TJ; Stojanov P; Cho J; Lawrence MS; Getz G; Brägelmann J; DeBoer R; Weichselbaum RR; Langerman A; Portugal L; Blair E; Stenson K; Lingen MW; Cohen EE; Vokes EE; White KP; Hammerman PS
    Clin Cancer Res; 2015 Feb; 21(3):632-41. PubMed ID: 25056374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The head and neck cancer cell oncogenome: a platform for the development of precision molecular therapies.
    Martin D; Abba MC; Molinolo AA; Vitale-Cross L; Wang Z; Zaida M; Delic NC; Samuels Y; Lyons JG; Gutkind JS
    Oncotarget; 2014 Oct; 5(19):8906-23. PubMed ID: 25275298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons learned from next-generation sequencing in head and neck cancer.
    Loyo M; Li RJ; Bettegowda C; Pickering CR; Frederick MJ; Myers JN; Agrawal N
    Head Neck; 2013 Mar; 35(3):454-63. PubMed ID: 22907887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing.
    Chung CH; Guthrie VB; Masica DL; Tokheim C; Kang H; Richmon J; Agrawal N; Fakhry C; Quon H; Subramaniam RM; Zuo Z; Seiwert T; Chalmers ZR; Frampton GM; Ali SM; Yelensky R; Stephens PJ; Miller VA; Karchin R; Bishop JA
    Ann Oncol; 2015 Jun; 26(6):1216-1223. PubMed ID: 25712460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NOTCH Pathway in Head and Neck Squamous Cell Carcinoma.
    Fukusumi T; Califano JA
    J Dent Res; 2018 Jun; 97(6):645-653. PubMed ID: 29489439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NOTCH1 Signaling in Head and Neck Squamous Cell Carcinoma.
    Shah PA; Huang C; Li Q; Kazi SA; Byers LA; Wang J; Johnson FM; Frederick MJ
    Cells; 2020 Dec; 9(12):. PubMed ID: 33322834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between EGFR variant III, HPV, p16, c-MET, EGFR gene copy number and response to EGFR inhibitors in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Chau NG; Perez-Ordonez B; Zhang K; Pham NA; Ho J; Zhang T; Ludkovski O; Wang L; Chen EX; Tsao MS; Kamel-Reid S; Siu LL
    Head Neck Oncol; 2011 Feb; 3():11. PubMed ID: 21352589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent mutations in TP53 and CDKN2A found by next-generation sequencing of head and neck cancer cell lines.
    Nichols AC; Yoo J; Palma DA; Fung K; Franklin JH; Koropatnick J; Mymryk JS; Batada NN; Barrett JW
    Arch Otolaryngol Head Neck Surg; 2012 Aug; 138(8):732-9. PubMed ID: 22911296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct effects of alcohol consumption and smoking on genetic alterations in head and neck carcinoma.
    Urashima M; Hama T; Suda T; Suzuki Y; Ikegami M; Sakanashi C; Akutsu T; Amagaya S; Horiuchi K; Imai Y; Mezawa H; Noya M; Nakashima A; Mafune A; Kato T; Kojima H
    PLoS One; 2013; 8(11):e80828. PubMed ID: 24278325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel insight into mutational landscape of head and neck squamous cell carcinoma.
    Gaykalova DA; Mambo E; Choudhary A; Houghton J; Buddavarapu K; Sanford T; Darden W; Adai A; Hadd A; Latham G; Danilova LV; Bishop J; Li RJ; Westra WH; Hennessey P; Koch WM; Ochs MF; Califano JA; Sun W
    PLoS One; 2014; 9(3):e93102. PubMed ID: 24667986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signatures of somatic mutations and gene expression from p16INK4A positive head and neck squamous cell carcinomas (HNSCC).
    Saba NF; Dinasarapu AR; Magliocca KR; Dwivedi B; Seby S; Qin ZS; Patel M; Griffith CC; Wang X; El-Deiry M; Steuer CE; Kowalski J; Shin DM; Zwick ME; Chen ZG
    PLoS One; 2020; 15(9):e0238497. PubMed ID: 32986729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HEY1 is expressed independent of NOTCH1 and is associated with poor prognosis in head and neck squamous cell carcinoma.
    Rettig EM; Bishop JA; Agrawal N; Chung CH; Sharma R; Zamuner F; Li RJ; Koch WM; Califano JA; Guo T; Gaykalova DA; Fakhry C
    Oral Oncol; 2018 Jul; 82():168-175. PubMed ID: 29909892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mutational spectrum of squamous-cell carcinoma of the head and neck: targetable genetic events and clinical impact.
    Mountzios G; Rampias T; Psyrri A
    Ann Oncol; 2014 Oct; 25(10):1889-1900. PubMed ID: 24718888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.
    Uribe P; Gonzalez S
    Pathol Res Pract; 2011 Jun; 207(6):337-42. PubMed ID: 21531084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 97.